Results 21 to 30 of about 70,737 (298)

Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine

open access: yesClinical and Experimental Hypertension, 2023
Objectives To investigate the actions of amlodipine-folic acid (amlodipine-FA) preparation on hypertension and cardiovascular in renal hypertensive rats with hyperhomocysteinemia (HHcy), so as to provide experimental basis for clinical research of ...
Li Li   +5 more
doaj   +1 more source

Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension

open access: yesPharmacogenomics and Personalized Medicine, 2021
Background Amlodipine is one of the most used members of calcium channel blockers (CCB), available to treat hypertension. It is mainly metabolized by the Cytochrome P450 3A4/5 (CYP3A4/5) in the liver.
Hao Liang   +9 more
semanticscholar   +1 more source

CURRENT ANALYTICAL METHODS FOR AMLODIPINE AND ITS FORMULATIONS: A REVIEW [PDF]

open access: yesJournal CleanWAS, 2017
The use of amlodipine is very common due to the effects of amlodipine on hypertension and coronary artery disease (CAD) like chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented CAD.
A.b. M. Helal   +5 more
doaj   +1 more source

Effect of Co-Administration of Curcumin with Amlodipine in Hypertension

open access: yesNutrients, 2021
Curcumin, a curcuminoid known as the main bioactive compound of turmeric, is used in foods, cosmetics, and pharmaceutical products. Amlodipine is a general antihypertensive drug used in combination with various other antihypertensive agents.
Somin Lee   +3 more
semanticscholar   +1 more source

Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records

open access: yesDrugs - Real World Outcomes, 2020
Background The effectiveness of amlodipine has been reported in clinical trials in India. However, real-world data on the effectiveness of amlodipine in India is limited.
Mohammed Yunus Khan   +8 more
doaj   +1 more source

CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its pleiotropic effect (influence on endothelial function and antiatherogenic action) is presented.
M. V. Leonova
doaj   +1 more source

Factors influencing the relationship between the dose of amlodipine required for blood pressure control and change in blood pressure in hypertensive cats [PDF]

open access: yes, 2016
BACKGROUND: Hypertension is a common problem in elderly cats. In most cats, systolic blood pressure (SBP) of
Bijsmans, E S   +5 more
core   +2 more sources

Randomized placebo-controlled clinical trial of a new chewable formulation of amlodipine for the treatment of hypertension in client-owned cats [PDF]

open access: yes, 2015
BACKGROUND: There is an unmet clinical need for a cat‐specific formulation of amlodipine to treat hypertensive cats. OBJECTIVES: To assess the efficacy of chewable amlodipine tablets in reducing systolic blood pressure (SBP) in cats diagnosed with ...
Brown   +14 more
core   +2 more sources

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and ...
M. A. Maksimova   +2 more
doaj   +3 more sources

A survey of Top 200 Drugs—Inconsistent Practice of Drug Strength Expression for Drugs Containing Salt Forms [PDF]

open access: yes, 2012
Many ionizable drugs are developed and marketed as salt forms. However, there are no clear US regulatory guidelines on drug strength labeling for salts. The strengths of some drugs are expressed as salts and some as free acids/bases.
Prohotsky, Daniel, Zhao, Fang
core   +2 more sources

Home - About - Disclaimer - Privacy